Atai life sciences to participate in upcoming january investor conference

New york, jan. 10, 2022 (globe newswire) -- atai life sciences n.v. (nasdaq: atai) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the following upcoming investor conference today:
ATAI Ratings Summary
ATAI Quant Ranking